logo

[Press Release] iNtRON has confirmed the efficacy of BAL200, a novel e..

[Press Release] iNtRON is finalizing the SAL200 Tech Transfer

[Press Release] iNtRON developed advanced bacteriophage engineering pl..

[Press Release] iNtRON completes the sponsorship transfer process for ..

[Press Release] iNtRON developed New CRISPR/Cas technology specific fo..

[Press Release] iNtRON Confirms Efficacy of CDL200 Against CDI Clinica..

[Press Release] iNtRON to Seek a New Clinical Partner for SAL200 Endol..

[Press Release] iNtRON Completes GLP-TOX Studies of BAL200

[Press Release] iNtRON Biotechnology, Inc., Launches New Website

Immune & Immunotherapeutics